Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 174

1.

Addressing diversity in tuberculosis using multidimensional approaches.

Lerm M, Dockrell HM.

J Intern Med. 2018 May 27. doi: 10.1111/joim.12776. [Epub ahead of print]

PMID:
29804295
2.

A Serum Circulating miRNA Signature for Short-Term Risk of Progression to Active Tuberculosis Among Household Contacts.

Duffy FJ, Thompson E, Downing K, Suliman S, Mayanja-Kizza H, Boom WH, Thiel B, Weiner Iii J, Kaufmann SHE, Dover D, Tabb DL, Dockrell HM, Ottenhoff THM, Tromp G, Scriba TJ, Zak DE, Walzl G; GC6-74 Consortium.

Front Immunol. 2018 Apr 13;9:661. doi: 10.3389/fimmu.2018.00661. eCollection 2018.

3.

Post-immunization leucocytosis and its implications for the management of febrile infants.

Prentice S, Kamushaaga Z, Nash SB, Elliott AM, Dockrell HM, Cose S.

Vaccine. 2018 May 11;36(20):2870-2875. doi: 10.1016/j.vaccine.2018.03.026. Epub 2018 Apr 11.

4.

Complement C1q expression in Erythema nodosum leprosum.

Negera E, Walker SL, Lema T, Aseffa A, Lockwood DN, Dockrell HM.

PLoS Negl Trop Dis. 2018 Mar 2;12(3):e0006321. doi: 10.1371/journal.pntd.0006321. eCollection 2018 Mar.

5.

The Effects of Prednisolone Treatment on Cytokine Expression in Patients with Erythema Nodosum Leprosum Reactions.

Negera E, Walker SL, Bobosha K, Bekele Y, Endale B, Tarekegn A, Abebe M, Aseffa A, Dockrell HM, Lockwood DN.

Front Immunol. 2018 Feb 9;9:189. doi: 10.3389/fimmu.2018.00189. eCollection 2018.

6.

Africa-wide evaluation of host biomarkers in QuantiFERON supernatants for the diagnosis of pulmonary tuberculosis.

Chegou NN, Sutherland JS, Namuganga AR, Corstjens PL, Geluk A, Gebremichael G, Mendy J, Malherbe S, Stanley K, van der Spuy GD, Kriel M, Loxton AG, Kriel B, Simukonda F, Bekele Y, Sheehama JA, Nelongo J, van der Vyver M, Gebrexabher A, Hailu H, Esterhuyse MM, Rosenkrands I, Aagard C, Kidd M, Kassa D, Mihret A, Howe R, Cliff JM, Crampin AC, Mayanja-Kizza H, Kaufmann SHE, Dockrell HM, Ottenhoff THM, Walzl G; AE-TBC consortium.

Sci Rep. 2018 Feb 8;8(1):2675. doi: 10.1038/s41598-018-20855-7.

7.

Tuberculosis vaccines: Opportunities and challenges.

Zhu B, Dockrell HM, Ottenhoff THM, Evans TG, Zhang Y.

Respirology. 2018 Apr;23(4):359-368. doi: 10.1111/resp.13245. Epub 2018 Jan 17. Review.

8.

Increased activated memory B-cells in the peripheral blood of patients with erythema nodosum leprosum reactions.

Negera E, Walker SL, Bekele Y, Dockrell HM, Lockwood DN.

PLoS Negl Trop Dis. 2017 Dec 18;11(12):e0006121. doi: 10.1371/journal.pntd.0006121. eCollection 2017 Dec.

9.

TBVAC2020: Advancing Tuberculosis Vaccines from Discovery to Clinical Development.

Kaufmann SHE, Dockrell HM, Drager N, Ho MM, McShane H, Neyrolles O, Ottenhoff THM, Patel B, Roordink D, Spertini F, Stenger S, Thole J, Verreck FAW, Williams A; TBVAC2020 Consortium.

Front Immunol. 2017 Oct 4;8:1203. doi: 10.3389/fimmu.2017.01203. eCollection 2017. Review.

10.

Clinico-pathological features of erythema nodosum leprosum: A case-control study at ALERT hospital, Ethiopia.

Negera E, Walker SL, Girma S, Doni SN, Tsegaye D, Lambert SM, Idriss MH, Tsegay Y, Dockrell HM, Aseffa A, Lockwood DN.

PLoS Negl Trop Dis. 2017 Oct 13;11(10):e0006011. doi: 10.1371/journal.pntd.0006011. eCollection 2017 Oct.

11.

Assay optimisation and technology transfer for multi-site immuno-monitoring in vaccine trials.

Smith SG, Harris SA, Satti I, Bryan D, Walker KB, Dockrell HM, McShane H, Ho MM.

PLoS One. 2017 Oct 11;12(10):e0184391. doi: 10.1371/journal.pone.0184391. eCollection 2017.

12.

T-cell regulation in Erythema Nodosum Leprosum.

Negera E, Walker SL, Bobosha K, Howe R, Aseffa A, Dockrell HM, Lockwood DN.

PLoS Negl Trop Dis. 2017 Oct 9;11(10):e0006001. doi: 10.1371/journal.pntd.0006001. eCollection 2017 Oct.

13.

New Insight into the Pathogenesis of Erythema Nodosum Leprosum: The Role of Activated Memory T-Cells.

Negera E, Bobosha K, Walker SL, Endale B, Howe R, Aseffa A, Dockrell HM, Lockwood DN.

Front Immunol. 2017 Sep 15;8:1149. doi: 10.3389/fimmu.2017.01149. eCollection 2017.

14.

What Have We Learnt about BCG Vaccination in the Last 20 Years?

Dockrell HM, Smith SG.

Front Immunol. 2017 Sep 13;8:1134. doi: 10.3389/fimmu.2017.01134. eCollection 2017. Review.

15.

The UK ME/CFS Biobank for biomedical research on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Multiple Sclerosis.

Lacerda EM, Bowman EW, Cliff JM, Kingdon CC, King EC, Lee JS, Clark TG, Dockrell HM, Riley EM, Curran H, Nacul L.

Open J Bioresour. 2017;4. pii: 4. doi: 10.5334/ojb.28. Epub 2017 Feb 20.

16.
17.

Working together toward vaccines and biomarkers in the real world.

Dockrell HM.

Hum Vaccin Immunother. 2017 Jul 3;13(7):1492-1494. doi: 10.1080/21645515.2017.1322443. Epub 2017 Jun 2. No abstract available.

18.

Association of slow recovery of Mycobacterium africanum-infected patients posttreatment with high content of Persister-Like bacilli in pretreatment sputum.

Tientcheu LD, Bell A, Secka O, Ayorinde A, Otu J, Garton NJ, Sutherland JS, Ota MO, Antonio M, Dockrell HM, Kampmann B, Barer MR.

Int J Mycobacteriol. 2016 Dec;5 Suppl 1:S99-S100. doi: 10.1016/j.ijmyco.2016.09.033. Epub 2016 Nov 11.

19.

Maternal BCG scar is associated with increased infant proinflammatory immune responses.

Mawa PA, Webb EL, Filali-Mouhim A, Nkurunungi G, Sekaly RP, Lule SA, Prentice S, Nash S, Dockrell HM, Elliott AM, Cose S.

Vaccine. 2017 Jan 5;35(2):273-282. doi: 10.1016/j.vaccine.2016.11.079. Epub 2016 Nov 30.

20.

Polyfunctional CD4 T-cells correlate with in vitro mycobacterial growth inhibition following Mycobacterium bovis BCG-vaccination of infants.

Smith SG, Zelmer A, Blitz R, Fletcher HA, Dockrell HM.

Vaccine. 2016 Oct 17;34(44):5298-5305. doi: 10.1016/j.vaccine.2016.09.002. Epub 2016 Sep 9.

Supplemental Content

Loading ...
Support Center